Profil
Anne Bowdidge is currently the Head-Investor & Media Relations at Adicet Bio, Inc. and the Head-Investor Relations at AN2 Therapeutics, Inc. Previously, she worked as the Senior Director-Investor Relations at Medivation LLC (California) from 2012 to 2017 and as the Head-Investor & Media Relations at Anthera Pharmaceuticals, Inc.
Postes actifs de Anne Bowdidge
| Sociétés | Poste | Début |
|---|---|---|
| ADICET BIO, INC. | Investor Relations Contact | - |
| AN2 THERAPEUTICS, INC. | Investor Relations Contact | - |
Anciens postes connus de Anne Bowdidge
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVATION INC | Investor Relations Contact | 01/02/2017 |
| ANTHERA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| AN2 THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
